FDA.reportPublic FDA data

Application 076105

Type
ANDA
Sponsor
BARR

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TRI-LEGEST FEETHINYL ESTRADIOL; NORETHINDRONE ACETATETABLET;ORAL-280.02MG,0.03MG,0.035MG;1MG,1MG,1MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0555-9032Tri-Legest FeNorethindrone Acetate and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9032Tri-Legest FeNorethindrone Acetate and Ethinyl EstradiolTeva Pharmaceuticals USA,ANDACurrent
0555-9032Tri-Legest FeNorethindrone Acetate and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9032Tri-Legest FeNorethindrone Acetate and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9032Tri-Legest FeNorethindrone Acetate and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9032Tri-Legest FeNorethindrone Acetate and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent